Independent advisers concluded that HRA Pharma’s application indicated that the benefit of allowing Opill to be sold without a prescription outweighed the risk of consumers taking it improperly.
Related posts:
Opioid lawsuits on verge of settlements with 4 companies
NFL: Covid outbreaks among unvaccinated players could mean forfeits
Confusion over Covid-19 boosters lingers as states roll out shots
U.S. to defer 33M Covid vaccine doses to Africa
Dems’ drug pricing dreams crash into reality in social spending tumult
Pfizer asks FDA to authorize Covid shot for children under 5
‘I almost lost my baby’: Parents demand answers from FDA
Global abortion-rights advocates worry their countries are next if Roe falls
FDA advisers endorse emergency use of Moderna Covid-19 vaccine in babies, toddlers
‘Dangerous and unacceptable’: White House condemns efforts to stop pharmacies from dispensing abortion pills
‘We can win’: Whitmer repeals Michigan’s 1931 abortion ban
Texas judge halts FDA approval of abortion pill
